Literature DB >> 1310583

Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus.

D L Barnard1, J H Huffman, J L Morris, S G Wood, B G Hughes, R W Sidwell.   

Abstract

A number of anthraquinones, anthrones and anthraquinone derivatives were evaluated for antiviral activity against human cytomegalovirus (HCMV) as well as for cytotoxicity. Of those compounds evaluated, quinalizarin, emodin, rhein, hypericin, protohypericin, alizarin, emodin bianthrone and emodin anthrone showed antiviral activity against a normal laboratory HCMV strain, AD-169. When tested against a ganciclovir-resistant strain of HCMV, the EC50 values for quinalizarin, rhein and alizarin were superior to the values obtained for the AD-169 strain of HCMV. These results suggest that these compounds will be useful as prototypes for synthesizing a class of anti-HCMV drugs that are effective against ganciclovir-sensitive and -resistant strains of HCMV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310583     DOI: 10.1016/0166-3542(92)90091-i

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  30 in total

1.  Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.

Authors:  R Kerb; J Brockmöller; B Staffeldt; M Ploch; I Roots
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

2.  Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases.

Authors:  Francesca Esposito; Tatyana Kharlamova; Simona Distinto; Luca Zinzula; Yung-Chi Cheng; Ginger Dutschman; Giovanni Floris; Patrick Markt; Angela Corona; Enzo Tramontano
Journal:  FEBS J       Date:  2011-03-16       Impact factor: 5.542

Review 3.  Experimental and theoretical studies of emodin interacting with a lipid bilayer of DMPC.

Authors:  Antonio R da Cunha; Evandro L Duarte; Hubert Stassen; M Teresa Lamy; Kaline Coutinho
Journal:  Biophys Rev       Date:  2017-09-22

4.  Production of anthraquinones, phenolic compounds and biological activities from hairy root cultures of Polygonum multiflorum Thunb.

Authors:  Muthu Thiruvengadam; Nagella Praveen; Eun-Hye Kim; Seung-Hyun Kim; Ill-Min Chung
Journal:  Protoplasma       Date:  2013-10-03       Impact factor: 3.356

5.  The content of secondary phenol metabolites in pruned leaves of Aloe arborescens, a comparison between two methods: leaf exudates and leaf water extract.

Authors:  Yitzchak Gutterman; Elena Chauser-Volfson
Journal:  J Nat Med       Date:  2008-05-10       Impact factor: 2.343

Review 6.  Anthraquinones and Derivatives from Marine-Derived Fungi: Structural Diversity and Selected Biological Activities.

Authors:  Mireille Fouillaud; Mekala Venkatachalam; Emmanuelle Girard-Valenciennes; Yanis Caro; Laurent Dufossé
Journal:  Mar Drugs       Date:  2016-03-25       Impact factor: 5.118

7.  Antiviral activities of anthraquinones, bianthrones and hypericin derivatives from lichens.

Authors:  P A Cohen; J B Hudson; G H Towers
Journal:  Experientia       Date:  1996-02-15

8.  Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures.

Authors:  C-Y Hsiang; T-Y Ho
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

9.  Rhein Elicits In Vitro Cytotoxicity in Primary Human Liver HL-7702 Cells by Inducing Apoptosis through Mitochondria-Mediated Pathway.

Authors:  Guy-Armel Bounda; Wang Zhou; Dan-Dan Wang; Feng Yu
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-14       Impact factor: 2.629

10.  Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.

Authors:  Zohaib Alam; Zainab Al-Mahdi; Yali Zhu; Zachary McKee; Deborah S Parris; Hardik I Parikh; Glen E Kellogg; Alison Kuchta; Michael A McVoy
Journal:  Antiviral Res       Date:  2014-12-10       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.